Additional file 3 of Effects of monoglyceride blend on systemic and intestinal immune responses, and gut health of weaned pigs experimentally infected with a pathogenic Escherichia coli
Creators: name: Park, Sangwoo
name: Sun, Shuhan
name: Kovanda, Lauren
name: Sokale, Adebayo O.
name: Barri, Adriana
name: Kim, Kwangwook
name: Li, Xunde
name: Liu, Yanhong
Publisher: name: figshare
Year: 2024
Subjects: subject: Space Science
subject: Medicine
subject: Microbiology
subject: FOS: Biological sciences
subject: Physiology
subject: Biotechnology
subject: Chemical Sciences not elsewhere classified
subject: Ecology
subject: Immunology
subject: FOS: Clinical medicine
subject: Infectious Diseases
subject: FOS: Health sciences
subject: Virology

description: Additional file 3: Fig. S3 Significantly changed pathways in serum between the control and monoglycerides groups on d 5 (A) and d 14 (C) post-inoculation, respectively. The x-axis represents the pathway impact values and the y-axis represents the −log(P) values from the pathway enrichment analysis. Metabolite set enrichment analysis shows the metabolic pathways were enriched in control compared with monoglycerides on d 5 (B) and d 14 (D) post-inoculation, respectively. Both pathway analysis and metabolite set enrichment analysis were performed using identified metabolites with VIP &gt; 1. Fig. S4 Significantly changed pathways in serum between the control and high-dose zinc oxide (ZNO) groups on d 5 (A) and d 14 (C) post-inoculation, respectively. The x-axis represents the pathway impact values and the y-axis represents the −log(P) values from the pathway enrichment analysis. Metabolite set enrichment analysis shows the metabolic pathways were enriched in control compared with ZNO on d 5 (B) and d 14 (D) post-inoculation, respectively. Both pathway analysis and metabolite set enrichment analysis were performed using identified metabolites with VIP &gt; 1. Fig. S5 Significantly changed pathways in serum between the monoglycerides and high-dose zinc oxide (ZNO) groups on d 5 (A) and d 14 (C) post-inoculation, respectively. The x-axis represents the pathway impact values and the y-axis represents the −log(P) values from the pathway enrichment analysis. Metabolite set enrichment analysis shows the metabolic pathways were enriched in monoglycerides compared with ZNO on d 5 (B) and d 14 (D) post-inoculation, respectively. Both pathway analysis and metabolite set enrichment analysis were performed using identified metabolites with VIP &gt; 1. Fig. S6 Significantly changed pathways in serum between the monoglycerides and antibiotic groups on d 5 (A) and d 14 (C) post-inoculation, respectively. The x-axis represents the pathway impact values and the y-axis represents the −log(P) values from the pathway enrichment analysis. Metabolite set enrichment analysis shows the metabolic pathways were enriched in monoglycerides compared with antibiotic on d 5 (B) and d 14 (D) post-inoculation, respectively. Both pathway analysis and metabolite set enrichment analysis were performed using identified metabolites with VIP &gt; 1. Fig. S7 Significantly changed pathways in serum between the high-dose zinc oxide (ZNO) and antibiotic groups on d 5 (A) and d 14 (C) post-inoculation, respectively. The x-axis represents the pathway impact values and the y-axis represents the −log(P) values from the pathway enrichment analysis. Metabolite set enrichment analysis shows the metabolic pathways were enriched in ZNO compared with antibiotic on d 5 (B) and d 14 (D) post-inoculation, respectively. Both pathway analysis and metabolite set enrichment analysis were performed using identified metabolites with VIP &gt; 1.